UnitedHealth Group Incorporated (NYSE:UNH) to Post Q1 2025 Earnings of $7.21 Per Share, Zacks Research Forecasts

UnitedHealth Group Incorporated (NYSE:UNHFree Report) – Analysts at Zacks Research upped their Q1 2025 earnings per share estimates for shares of UnitedHealth Group in a research report issued on Tuesday, April 30th. Zacks Research analyst D. Chatterjee now expects that the healthcare conglomerate will earn $7.21 per share for the quarter, up from their previous forecast of $7.01. The consensus estimate for UnitedHealth Group’s current full-year earnings is $27.60 per share. Zacks Research also issued estimates for UnitedHealth Group’s Q2 2025 earnings at $7.35 EPS, Q3 2025 earnings at $8.29 EPS and Q4 2025 earnings at $8.23 EPS.

A number of other analysts have also recently weighed in on UNH. Deutsche Bank Aktiengesellschaft increased their price target on shares of UnitedHealth Group from $545.00 to $562.00 and gave the stock a “buy” rating in a research note on Friday, April 19th. TD Cowen dropped their price target on UnitedHealth Group from $607.00 to $546.00 and set a “buy” rating on the stock in a research report on Wednesday, April 10th. Bank of America reiterated a “buy” rating and issued a $675.00 target price on shares of UnitedHealth Group in a research note on Thursday, March 7th. Oppenheimer reissued an “outperform” rating and issued a $610.00 price objective on shares of UnitedHealth Group in a research note on Wednesday, January 17th. Finally, Barclays increased their price target on shares of UnitedHealth Group from $534.00 to $560.00 and gave the stock an “overweight” rating in a report on Wednesday, April 17th. Four equities research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $570.05.

Check Out Our Latest Stock Analysis on UnitedHealth Group

UnitedHealth Group Trading Down 0.1 %

UNH opened at $492.45 on Friday. The business’s 50 day moving average is $482.32 and its two-hundred day moving average is $512.76. The firm has a market cap of $453.09 billion, a price-to-earnings ratio of 30.10, a price-to-earnings-growth ratio of 1.43 and a beta of 0.55. UnitedHealth Group has a 52 week low of $436.38 and a 52 week high of $554.70. The company has a quick ratio of 0.79, a current ratio of 0.85 and a debt-to-equity ratio of 0.69.

UnitedHealth Group (NYSE:UNHGet Free Report) last announced its quarterly earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $6.63 by $0.28. The company had revenue of $99.80 billion during the quarter, compared to the consensus estimate of $99.23 billion. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. UnitedHealth Group’s revenue for the quarter was up 8.6% on a year-over-year basis. During the same period in the previous year, the business earned $6.26 EPS.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently modified their holdings of the stock. Richelieu Gestion SA purchased a new position in UnitedHealth Group during the fourth quarter worth approximately $26,000. Robbins Farley acquired a new stake in UnitedHealth Group during the third quarter worth about $25,000. CGC Financial Services LLC lifted its stake in shares of UnitedHealth Group by 1,000.0% in the 4th quarter. CGC Financial Services LLC now owns 55 shares of the healthcare conglomerate’s stock valued at $29,000 after purchasing an additional 50 shares in the last quarter. True Wealth Design LLC acquired a new stake in UnitedHealth Group during the 4th quarter worth approximately $31,000. Finally, NewSquare Capital LLC grew its stake in UnitedHealth Group by 340.0% during the third quarter. NewSquare Capital LLC now owns 66 shares of the healthcare conglomerate’s stock worth $33,000 after buying an additional 51 shares during the period. Institutional investors and hedge funds own 87.86% of the company’s stock.

Insider Buying and Selling

In other news, CAO Thomas E. Roos sold 858 shares of the business’s stock in a transaction on Friday, February 23rd. The stock was sold at an average price of $525.79, for a total value of $451,127.82. Following the completion of the transaction, the chief accounting officer now directly owns 32,289 shares of the company’s stock, valued at $16,977,233.31. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,236 shares of the stock in a transaction on Friday, March 8th. The stock was sold at an average price of $483.48, for a total transaction of $597,581.28. Following the transaction, the executive vice president now owns 9,364 shares of the company’s stock, valued at approximately $4,527,306.72. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, CAO Thomas E. Roos sold 858 shares of the company’s stock in a transaction on Friday, February 23rd. The shares were sold at an average price of $525.79, for a total value of $451,127.82. Following the completion of the transaction, the chief accounting officer now owns 32,289 shares of the company’s stock, valued at $16,977,233.31. The disclosure for this sale can be found here. Insiders own 0.35% of the company’s stock.

UnitedHealth Group Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, March 19th. Stockholders of record on Monday, March 11th were given a $1.88 dividend. The ex-dividend date was Friday, March 8th. This represents a $7.52 annualized dividend and a dividend yield of 1.53%. UnitedHealth Group’s dividend payout ratio is presently 45.97%.

About UnitedHealth Group

(Get Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

See Also

Earnings History and Estimates for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.